SCHEMBL19117682

SCHEMBL19117682

Oc1cn(CC2CC2)c2ccccc12

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR1 P21554 11/20 0.48
CNR2 P34972 9/20 0.48
HTR2A P28223 1/20 0.47
HTR2C P28335 1/20 0.47
PADI4 Q9UM07 1/20 0.43
PDE4A P27815 2/20 0.43
PDE4B Q07343 2/20 0.43
PDE4C Q08493 2/20 0.43
PDE4D Q08499 2/20 0.43
ABCC2 Q92887 1/20 0.42
HDAC3 O15379 1/20 0.41
HDAC4 P56524 1/20 0.41
HDAC1 Q13547 1/20 0.41
HDAC7 Q8WUI4 1/20 0.41
HDAC2 Q92769 1/20 0.41
HDAC10 Q969S8 1/20 0.41
HDAC11 Q96DB2 1/20 0.41
HDAC8 Q9BY41 1/20 0.41
HDAC6 Q9UBN7 1/20 0.41
HDAC9 Q9UKV0 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27691989 0.80 DHFR (0.51) CNR1CNR2
SCHEMBL17553833 0.79 PDE4A (0.46) CNR1CNR2PADI4PDE4APDE4B
SCHEMBL21600842 0.79 MEN1 (0.49) CNR1CNR2HTR2AHTR2CPADI4
SCHEMBL31230200 0.79 MEN1 (0.49) CNR1CNR2HTR2AHTR2CPADI4
SCHEMBL4334349 0.78 HTR2C (0.53) CNR1CNR2HTR2AHTR2C
SCHEMBL7291403 0.78 CNR1 (0.60) CNR1CNR2
SCHEMBL7291968 0.78 CNR1 (0.62) CNR1CNR2
SCHEMBL31370596 0.77 PADI4 (0.47) CNR1CNR2HTR2AHTR2CPADI4
SCHEMBL13949764 0.77 CNR1 (0.48) CNR1CNR2HTR2AHTR2CPADI4
SCHEMBL29071729 0.76 ALDH1A1 (0.54)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017120429-A1 SELECTIVE INHIBITORS OF CLINICALLY IMPORTANT MUTANTS OF THE EGFR TYROSINE KINASE CS Pharmasciences, Inc. (US) 2017-07-13 WO disclosed